BioInformant

Your Global Leader in Stem Cell Market Research

How To Avoid ACL Surgery With Stem Cell Treatment

By 1 Comment

Despite ACL surgeries being more readily available than ever before, torn knee ligaments are still one of the most dreaded injuries for athletes and other active people. The anterior cruciate ligament (ACL) is responsible for stabilizing the knee. If it tears after a sudden wrenching movement, then stability and ease of motion are destroyed. Until recently, ACL surgeries seemed to be the only way for patients to escape the pain, stiffness, and stability loss that comes with an ACL injury.

Fortunately, stem cell treatment may now represent a viable way for some patients to heal torn knee ligaments while avoiding invasive ACL surgeries.

Alternative To ACL Injuries? How Stem Cells Can Help

In this article:

  1. Why Seek an Alternative to ACL Surgery?
  2. How Stem Cell Treatment Addresses an ACL Injury
  3. The Stem Cell Procedure for an ACL Tear
  4. Will Your ACL Injury Respond Well to Stem Cell Treatment?

 

[Read more…]

I Peace expands its clinical-grade iPSC banking service leveraging mass manufacturing capability

By Leave a Comment

September 7, 2021, Palo Alto, California – I Peace, Inc. (CEO: Koji Tanabe), a Palo Alto-based biotech startup focusing on Nobel Prize-winning technology of induced pluripotent stem cells (iPSCs) expands its personalized iPSC banking service. I Peace launched its clinical-grade personalized iPSC banking service in 2020 in Japan and has already banked several individuals’ iPSCs. The company will collaborate with I’rom Group Co., Ltd. (Japan) to make the service available for clients at every corner of the country. Using this as proof of concept,  I Peace plans to launch the iPSC banking service in the U.S. as the next phase of its business expansion. [Read more…]

Stem Cell Treatment For Hair Loss

By 1 Comment

The latest development in stem cell research – stem cell treatment for hair loss – shows great promise for stimulating new hair growth. It addresses the problem of thinning hair for both men and women.

When hair growth slows with age, many people feel despondent, depressed, less confident, or unhappy. The prospect of a continuing downhill slide makes the situation  worse, which is why stem cell transplant for hair loss has become a large business in the last several decades. [Read more…]

Jacobio Enters Strategic Investment with Hebecell to Develop iPSC-derived NK Cell Therapy

By Leave a Comment

BEIJING and SHANGHAI and BOSTON, Aug. 31, 2021 — Jacobio Pharmaceuticals (“Jacobio”, 1167.HK) announced a strategic investment in the US-based biotech company Hebecell on August 31. Jacobio will collaborate with Hebecell to develop the next-generation natural killer cell therapy based on induced pluripotent stem cells (iPSC-NK).

Once the deal is completed, Jacobio chairman and CEO Dr. Yinxiang Wang will be appointed as Chairman of Hebecell. [Read more…]

How Human iPSCs are Revolutionizing Drug Discovery in 2021

By Leave a Comment

Drug discovery involves high cost and uncertain outcomes.  Only a few companies can take the risk of investing enormous amounts of money into research and testing, only to see undesirable side effects emerge during the final human clinical trials. In many cases, companies are spending millions of dollars to fail during clinical testing.

Now, some new medicines are being tested for safety on specialized cells developed from human pluripotent cell lines. Cells types which are frequently being using within drug discovery applications include heart (cardiomyocytes) and liver cells (hepatocytes), which are the organs where 80% of drug failures occur. [Read more…]

BioInformant's World-Class Clients